A Phase 1, Multiple‐Dose Study of Vedolizumab in Japanese Patients With Ulcerative Colitis

Although previous studies have shown that patients with ulcerative colitis may benefit from treatment with vedolizumab, a humanized monoclonal antibody targeting the α(4)β(7) integrin heterodimer, no data exist in Japanese populations. The aim of this phase 1, open‐label, multicenter study was to as...

Descripción completa

Detalles Bibliográficos
Autores principales: Kobayashi, Kiyonori, Suzuki, Yasuo, Watanabe, Kenji, Oda, Kazunori, Mukae, Miyuki, Yamada, Akihiro, Yamagami, Hirokazu, Nishimura, Akira, Okamoto, Hiroyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Pharmacokinetics/Pharmacodynamics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718004/
https://www.ncbi.nlm.nih.gov/pubmed/30192378
http://dx.doi.org/10.1002/jcph.1307

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718004/
https://www.ncbi.nlm.nih.gov/pubmed/30192378
http://dx.doi.org/10.1002/jcph.1307

Ejemplares similares